Sinew Pharma Inc Stock Code6634 Twois A Publicly Listed Biotech Company Dedicated On The Development Of Therapeutic Products For Solving Urgent And Important Unmet Medical Needs Sinew Aspires To Become A Leading Pharmaceutical Company By Actively Engaging In R&D For Drug Development Of Metabolic Dysfunction Associated Steatohepatitismashformerly Known As Non Alcoholic Steatohepatitisnashas Well As For The World S First Non Hepatotoxic Acetaminophen Current Pipeline Includes Six Productstwo Of Which Are Dedicated To Mash Treatmentthree Aim To Address Liver Toxicity Issues Arising From The Widely Used Painkiller Acetaminophen And Its Combinationse G With A Non Addictive Kappa Opioid For Postoperative Pain Management And One Serves As An Antidote For Acetaminophen Poisoning
